TLNRD1 is a CCM complex component and regulates endothelial barrier integrity




Ball, Neil J.; Ghimire, Sujan; Follain, Gautier; Pajari, Ada O.; Wurzinger, Diana; Vaitkevičiūtė, Monika; Cowell, Alana R.; Berki, Bence; Ivaska, Johanna; Paatero, Ilkka; Goult, Benjamin T.; Jacquemet, Guillaume

PublisherRockefeller University Press

2024

Journal of Cell Biology

The Journal of cell biology

J Cell Biol

e202310030

223

9

0021-9525

1540-8140

DOIhttps://doi.org/10.1083/jcb.202310030

https://rupress.org/jcb/article/223/9/e202310030/276861/TLNRD1-is-a-CCM-complex-component-and-regulates

https://research.utu.fi/converis/portal/detail/Publication/457256769



We previously identified talin rod domain-containing protein 1 (TLNRD1) as a potent actin-bundling protein in vitro. Here, we report that TLNRD1 is expressed in the vasculature in vivo. Its depletion leads to vascular abnormalities in vivo and modulation of endothelial cell monolayer integrity in vitro. We demonstrate that TLNRD1 is a component of the cerebral cavernous malformations (CCM) complex through its direct interaction with CCM2, which is mediated by a hydrophobic C-terminal helix in CCM2 that attaches to a hydrophobic groove on the four-helix domain of TLNRD1. Disruption of this binding interface leads to CCM2 and TLNRD1 accumulation in the nucleus and actin fibers. Our findings indicate that CCM2 controls TLNRD1 localization to the cytoplasm and inhibits its actin-bundling activity and that the CCM2-TLNRD1 interaction impacts endothelial actin stress fiber and focal adhesion formation. Based on these results, we propose a new pathway by which the CCM complex modulates the actin cytoskeleton and vascular integrity.


Research funded by Research Council of Finland (338537,325464,332402) | Academy of Finland (337530,337531,357910,357911) | Centre of Excellence (# 346131) | Biotechnology and Biological Sciences Research Council (BB/S007245/1) | Cancer Research UK (CRUK-A21671)


Last updated on 2025-27-01 at 19:16